Key result
Concentric hypertrophy in moderate AS is linked to ~26% higher mortality.
Why the study?
Because outcomes in aortic stenosis are driven by left ventricular condition rather than the valve, assessment of LV remodelling patterns seems important for risk stratification in moderate aortic stenosis.
Do abnormal left ventricular remodelling patterns increase the risk of mortality and aortic valve replacement in patients with moderate aortic stenosis?
Do abnormal left ventricular remodelling patterns increase the risk of mortality and aortic valve replacement in patients with moderate aortic stenosis?
In patients with moderate aortic stenosis, the presence of concentric hypertrophy is independently associated with an increased risk of all-cause mortality, highlighting the importance of LV assessment for risk stratification.
LV geometry assessment may refine risk stratification in moderate AS; extends observational data on remodeling without practice change.
Aims Moderate aortic stenosis (AS) is associated with an increased risk of adverse events. Because outcomes in patients with AS are ultimately driven by the condition of the left ventricle (LV) and not by the valve, assessment of LV remodelling seems important for risk stratification. This study evaluated the association between different LV remodelling patterns and outcomes in patients with moderate AS. Methods and results Patients with moderate AS (aortic valve area 1.0–1.5 cm2) were identified and stratified into four groups according to the LV remodelling pattern: normal geometry (NG), concentric remodelling (CR), concentric hypertrophy (CH), or eccentric hypertrophy (EH). Clinical outcomes were defined as all-cause mortality and a composite endpoint of all-cause mortality and aortic valve replacement (AVR). Of 1931 patients with moderate AS (age 73 ± 10 years, 52% men), 344 (18%) had NG, 469 (24%) CR, 698 (36%) CH, and 420 (22%) EH. Patients with CH and EH showed higher 3-year mortality rates (28% and 32%, respectively) when compared with patients with NG (19%) (P < 0.001). After multivariable adjustment, CH remained independently associated with mortality (HR 1.258, 95% CI 1.016–1.558; P = 0.035), whereas both CH (HR 1.291, 95% CI 1.088–1.532; P = 0.003) and EH (HR 1.217, 95% CI 1.008–1.470; P = 0.042) were associated with the composite endpoint of death or AVR. Conclusion In patients with moderate AS, those who develop CH already have an increased risk of all-cause mortality. Assessment of the LV remodelling patterns may identify patients at higher risk of adverse events, warranting closer surveillance, and possibly earlier intervention.
No takes yet. Share an insight, caveat, or question.
Stassen et al. (2022) studied this question. Concentric hypertrophy in patients with moderate aortic stenosis is independently associated with increased mortality (HR 1.258) and higher rates of adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: